Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis

Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis

The aim of the review was to evaluate patient and treatment characteristics for patients with metastatic castration-resistant prostate cancer (mCRPC) treated with PSMA radioligand therapy (PRLT) associated with above-average outcome. The systematic review and meta-analysis followed recommendations b...

Full description

Bibliographic Details
Main Authors: Finn Edler von Eyben, Glenn Bauman, Rie von Eyben, Kambiz Rahbar, Cigdem Soydal, Alexander R. Haug, Irene Virgolini, Harshad Kulkarni, Richard Baum, Giovanni Paganelli
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Molecular Sciences
Subjects:
adverse effects
decline of prostate specific antigen
metastases
overall survival
predictive factors
prostate cancer
Online Access:https://www.mdpi.com/1422-0067/21/23/9054

Internet

https://www.mdpi.com/1422-0067/21/23/9054

Similar Items